Navidea Biopharmaceuticals Inc (NAVB)
0.04
0.00 (0.00%)
USD |
OTCM |
Apr 26, 10:47
Navidea Biopharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | -8.10K% |
| September 30, 2022 | -1.69K% |
| June 30, 2022 | 92.74% |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | 98.79% |
| June 30, 2020 | 96.00% |
| March 31, 2020 | 96.00% |
| December 31, 2019 | 95.97% |
| September 30, 2019 | 96.02% |
| June 30, 2019 | 98.50% |
| March 31, 2019 | -94.48% |
| December 31, 2018 | 34.86% |
| September 30, 2018 | -70.76% |
| June 30, 2018 | 86.61% |
| March 31, 2018 | 60.00% |
| December 31, 2017 | 59.99% |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 |
| Date | Value |
|---|---|
| September 30, 2016 | 99.84% |
| June 30, 2016 | 99.93% |
| March 31, 2016 | 99.84% |
| December 31, 2015 | 84.16% |
| September 30, 2015 | 88.50% |
| June 30, 2015 | 88.40% |
| March 31, 2015 | 78.70% |
| December 31, 2014 | 85.69% |
| September 30, 2014 | 64.10% |
| June 30, 2014 | 74.83% |
| March 31, 2014 | 74.30% |
| December 31, 2013 | 71.60% |
| September 30, 2013 | 81.16% |
| June 30, 2013 | 46.01% |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-8.10K%
Minimum
Dec 2022
98.79%
Maximum
Sep 2020
-1.01K%
Average
96.00%
Median
Jun 2020
Gross Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 77.03% |
| Xtant Medical Holdings Inc | 60.97% |
| Asensus Surgical Inc | 21.47% |
| Senseonics Holdings Inc | 13.56% |